{
  "trial_id": "NCT03664726",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, fasting plasma glucose (FPG) levels, 2-hour glucose levels after Oral Glucose Tolerance Test (OGTT), hemoglobin A1c (HbA1c) levels, history of hypertension, history of hyperlipidemia, blood pressure, LDL cholesterol levels, non-HDL cholesterol levels, medication use for hypertension, medication use for dyslipidemia, exclusion of Type 2 Diabetes, pregnancy status, psychiatric disorder status, intellectual impairment status, medication use affecting glucose levels, willingness to eat study food, prior participation in similar studies, discounting criteria status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "hbA1c",
          "hemoglobin A1c (HbA1c) levels"
        ],
        [
          "Delay discounting",
          "discounting criteria status"
        ],
        [
          "Reinforcing Value of Food; Intensity",
          "Reinforcing Value of Food"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Site Enrollment"
      ],
      "remaining_candidate_features": [
        "fasting plasma glucose (FPG) levels",
        "2-hour glucose levels after Oral Glucose Tolerance Test (OGTT)",
        "history of hypertension",
        "history of hyperlipidemia",
        "blood pressure",
        "LDL cholesterol levels",
        "non-HDL cholesterol levels",
        "medication use for hypertension",
        "medication use for dyslipidemia",
        "exclusion of Type 2 Diabetes",
        "pregnancy status",
        "psychiatric disorder status",
        "intellectual impairment status",
        "medication use affecting glucose levels",
        "willingness to eat study food",
        "prior participation in similar studies"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Fasting Plasma Glucose, 2-hour Glucose, Hemoglobin A1c, Blood Pressure, LDL Cholesterol, Non-HDL Cholesterol, Comorbid Hypertension, Comorbid Hyperlipidemia,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "hbA1c",
          "Hemoglobin A1c"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Delay discounting",
        "Site Enrollment",
        "Reinforcing Value of Food; Intensity"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Fasting Plasma Glucose",
        "2-hour Glucose",
        "Blood Pressure",
        "LDL Cholesterol",
        "Non-HDL Cholesterol",
        "Comorbid Hypertension",
        "Comorbid Hyperlipidemia"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Fasting Plasma Glucose, Hemoglobin A1c, History of Hypertension, History of Hyperlipidemia, Comorbidities, Education Level, Income Level.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "hbA1c",
          "Hemoglobin A1c"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)",
        "Site Enrollment",
        "Delay discounting",
        "Reinforcing Value of Food; Intensity"
      ],
      "remaining_candidate_features": [
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Fasting Plasma Glucose",
        "History of Hypertension",
        "History of Hyperlipidemia",
        "Comorbidities",
        "Education Level",
        "Income Level"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), fasting plasma glucose (FPG), hemoglobin A1c (HbA1c), blood pressure, LDL cholesterol, non-fasting non-HDL cholesterol, history of hypertension, history of hyperlipidemia, medication use (e.g. Lisinopril, Diovan, Niacin, Lovastatin), education level, income level, employment status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "hbA1c",
          "hemoglobin A1c (HbA1c)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Delay discounting",
        "Site Enrollment",
        "Reinforcing Value of Food; Intensity"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "fasting plasma glucose (FPG)",
        "blood pressure",
        "LDL cholesterol",
        "non-fasting non-HDL cholesterol",
        "history of hypertension",
        "history of hyperlipidemia",
        "medication use (e.g. Lisinopril, Diovan, Niacin, Lovastatin)",
        "education level",
        "income level",
        "employment status"
      ]
    }
  }
}